Schmidt PT, Hartmann B, Bregenholt S et al (2000) Deficiency of the intestinal growth factor, glucagon-like peptide 2, in the colon of SCID mice with inflammatory bowel disease induced by transplantation of CD4+ T cells
Inadequate protein accelerates muscle loss, which lowers metabolic rate and makes long-term weight maintenance harder
Food and Drug Administration and request approval for orforglipron as a treatment for obesity by the end of 2025
When that builds up, you feel it as fatigue, slower recovery, and lower output
Stomach Discomfort: Some patients may experience bloating, abdominal pain, or indigestion while using GLP-1 medications
Driven by excessive lymphatic flow due to portal hypertension and possible rupture of serosal lymphatics